The American Epilepsy Society has long been a steadfast advocate for the epilepsy community—working to advance research, improve care, support clinicians, and strengthen the voice of the epilepsy community.
As the field of medicine grows more complex and ever evolving policy changes increasingly affect clinical practice and patient care, it’s become clear: to influence the broader medical landscape, AES must be in the room where national decisions are made—the American Medical Association’s (AMA) House of Delegates.
Why Now
The AMA House of Delegates is the principal policymaking body of organized medicine in the United States. “It’s where specialties come together to shape the future of healthcare policy—on issues from physician reimbursement to prior authorization reform, from telehealth access to artificial intelligence in clinical care. These are our issues.” said David Labiner, MD, FRSM, FANA, FAES, AES representative to the AMA Specialty and Service Society.
Today, AES member physicians rely on the voices of broader neurology or neurosurgery organizations to represent our perspective in AMA policy discussions. But epilepsy care is not one-size-fits-all, and the challenges we face as a field are distinct. To influence the AMA’s advocacy agenda directly and ensure that epilepsy-related concerns are prioritized, AES must secure its own seat in the House of Delegates. To do that, we need at least 20% of our Society’s physician membership to also be members of the AMA.